Scleroderma and Fibrosis Research Enhancement Act of 2015
Latest action · Oct 2, 2015 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 1, 2015
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Scleroderma and Fibrosis Research Enhancement Act of 2015
This bill requires the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to establish the National Commission on Scleroderma and Fibrosis Research. (Scleroderma and fibrosis are connective tissue conditions that cause hardening or scarring of skin and organs.)
The commission must develop a long-term, comprehensive plan for scleroderma and fibrosis research. The plan must: (1) prioritize research that has cross-cutting value and requires coordination across NIH, and (2) include specific steps for implementation of the research.
The commission must establish working groups to make research recommendations for the various organs and systems impacted by fibrotic illness.
The commission must be terminated not later than two years after establishment.
The NIAMS must create the Scleroderma and Fibrosis Working Group to oversee and assist with implementation of the long-term plan.Cosponsors 51
Members who signed on, in the order they did. Signatures ran from Oct 1, 2015 to Dec 12, 2016; 4 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NY | Charles B. Rangel | Original | Oct 1, 2015 |
| D-DC | Eleanor Holmes Norton | Original | Oct 1, 2015 |
| D-NY | Joseph Crowley | Original | Oct 1, 2015 |
| D-CA | Lois Capps | Original | Oct 1, 2015 |
| D-NY | Eliot L. Engel | Oct 2, 2015 | |
| D-MA | James P. McGovern | Oct 6, 2015 | |
| R-MO | Billy Long | Oct 8, 2015 | |
| R-PA | Michael G. Fitzpatrick | Oct 8, 2015 | |
| R-MO | Sam Graves | Oct 8, 2015 | |
| R-OH | Steve Stivers | Oct 9, 2015 | |
| D-NY | Louise McIntosh Slaughter | Oct 20, 2015 | |
| D-NY | Paul Tonko | Oct 20, 2015 | |
| R-NY | Richard L. Hanna | Oct 20, 2015 | |
| R-MO | Ann Wagner | Oct 21, 2015 | |
| R-MI | Bill Huizenga | Oct 21, 2015 | |
| D-NY | Steve Israel | Oct 21, 2015 | |
| D-NY | Yvette D. Clarke | Oct 21, 2015 | |
| R-NY | Christopher P. Gibson | Oct 28, 2015 | |
| D-NY | Hakeem S. Jeffries | Oct 28, 2015 | |
| D-PA | Matt Cartwright | Oct 28, 2015 | |
| D-VT | Peter Welch | Nov 3, 2015 | |
| R-MI | Candice S. Miller | Nov 16, 2015 | |
| D-NH | Ann M. Kuster | Dec 1, 2015 | |
| D-CO | Ed Perlmutter | Dec 11, 2015 | |
| D-ME | Chellie Pingree | Dec 15, 2015 | |
| D-CA | Mark Takano | Jan 12, 2016 | |
| D-FL | Alcee L. Hastings | Mar 23, 2016 | |
| D-NY | Kathleen M. Rice | Apr 14, 2016 | |
| D-OH | Joyce Beatty | May 10, 2016 | |
| D-MS | Bennie G. Thompson | May 16, 2016 | |
| D-FL | Frederica S. Wilson | Jun 10, 2016 | |
| D-CA | Ted Lieu | Jun 10, 2016 | |
| D-CA | Anna G. Eshoo | Jun 14, 2016 | |
| D-CA | Alan S. Lowenthal | Jun 15, 2016 | |
| D-MN | Richard M. Nolan | Jul 7, 2016 | |
| R-CO | Mike Coffman | Sep 8, 2016 | |
| D-CA | Zoe Lofgren | Sep 9, 2016 | |
| D-TX | Gene Green | Sep 14, 2016 | |
| D-CA | Adam B. Schiff | Sep 22, 2016 | |
| D-MI | Brenda L. Lawrence | Sep 22, 2016 | |
| D-MI | Daniel T. Kildee | Sep 22, 2016 | |
| R-IL | Robert J. Dold | Sep 22, 2016 | |
| D-MI | Debbie Dingell | Sep 28, 2016 | |
| R-SC | Mark Sanford | Sep 28, 2016 | |
| D-AZ | Ann Kirkpatrick | Nov 15, 2016 | |
| D-MD | John K. Delaney | Nov 15, 2016 | |
| D-NY | Sean Patrick Maloney | Nov 15, 2016 | |
| D-IL | Janice D. Schakowsky | Nov 29, 2016 | |
| D-IL | Daniel Lipinski | Dec 8, 2016 | |
| D-NY | Grace Meng | Dec 8, 2016 | |
| D-MA | Niki Tsongas | Dec 12, 2016 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Oct 1, 2015 |
| Health Subcommittee | Referred Oct 2, 2015 |
Actions 3
Everything that happened, newest first.
- Oct 2, 2015Referred to the Subcommittee on Health.
- Oct 1, 2015Introduced in House
- Oct 1, 2015Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 161, no. 143, October 1, 2015, page H6788.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 3431 | Scleroderma and Fibrosis Research Enhancement Act of 2016 | Related bill | Sep 28, 2016 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To coordinate and advance fibrosis research activities at the National Institutes of Health, and for other purposes.
- Short Titles as Introduced
- Scleroderma and Fibrosis Research Enhancement Act of 2015
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Oct 1, 2015Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
